Koya Keizo

Insider CIK 1325718 · SNTA Sr. VP, Drug Development

Track record

See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.

Ticker	Code	Trade	Filed	Shares	Price	Value	Owned after
SNTA SYNTA PHARMACEUTICALS CORP	A Award deriv	2012-03-06	2012-03-08	63,036	—	$0	63,036	SEC↗
SNTA SYNTA PHARMACEUTICALS CORP	S Sale	2012-03-01	2012-03-05	6,844	$4.70	$32.2K	12,999	SEC↗